Outbound Relationships |
Type |
Target |
Active |
Characteristic |
Refinability |
Group |
Values |
Haemophilus b polysaccharide + tetanus toxoid 10mcg/24mcg |
Is a |
Haemophilus b polysaccharide conjugate (diphtheria toxoid conjugate) vaccine |
false |
Inferred relationship |
Some |
|
|
Haemophilus b polysaccharide + tetanus toxoid 10mcg/24mcg |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Influenza virus vaccine |
false |
Inferred relationship |
Some |
|
|
Haemophilus b polysaccharide + tetanus toxoid 10mcg/24mcg |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Haemophilus influenzae type b vaccine |
false |
Inferred relationship |
Some |
|
|
Haemophilus b polysaccharide + tetanus toxoid 10mcg/24mcg |
Is a |
Haemophilus influenzae Type b + tetanus vaccine |
false |
Inferred relationship |
Some |
|
|
Haemophilus b polysaccharide + tetanus toxoid 10mcg/24mcg |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Tetanus toxoid |
false |
Inferred relationship |
Some |
|
|
Haemophilus b polysaccharide + tetanus toxoid 10mcg/24mcg |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Tetanus vaccine |
false |
Inferred relationship |
Some |
|
|